Molecular Assemblies Names Michael Kamdar as CEO

Xconomy San Diego — 

Molecular Assemblies, a San Diego biotech founded three years ago to advance a new technique for synthesizing sequence-specific DNA, has named Michael Kamdar as CEO and director. Kamdar was previously a co-founder of San Diego’s Genoa Pharmaceuticals, and continues to serve as a director at Genoa and Cellana, a local industrial biotech.

Kamdar has spent more than 25 years with such life sciences companies as Agouron Pharmaceuticals, Warner-Lambert, Pfizer, Anadys Pharmaceuticals, and VentiRx Pharmaceuticals. According to a statement from the company, Kamdar has helped to raise hundreds of millions of dollars for pharmaceutical and biotech companies, and has participated in strategic and corporate transactions totaling more than $1 billion.

William Efcavitch and Curt Becker founded Molecular Assemblies to develop a new method of synthesizing DNA. According to the company, their enzymatic approach produces long, high-quality, and sequence-specific DNA.